Chitosan-hyaluronic acid/nano silver composite sponges for drug resistant bacteria infected diabetic wounds

被引:199
作者
Anisha, B. S. [1 ]
Biswas, Raja [1 ]
Chennazhi, K. P. [1 ]
Jayakumar, R. [1 ]
机构
[1] Amrita Vishwa Vidyapeetham Univ, Amrita Inst Med Sci & Res Ctr, Amrita Ctr Nanosci & Mol Med, Kochi 682041, India
关键词
Chitosan-hyaluronic acid; Nano silver; Wound dressing-sponge-diabetic foot ulcers; IN-VITRO; STAPHYLOCOCCUS-AUREUS; ACID; NANOPARTICLES; DRESSINGS;
D O I
10.1016/j.ijbiomac.2013.09.011
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The aim of this work was to develop an antimicrobial sponge composed of chitosan, hyaluronic acid (HA) and nano silver (nAg) as a wound dressing for diabetic foot ulcers (DFU) infected with drug resistant bacteria. nAg (5-20 nm) was prepared and characterized. The nanocomposite sponges were prepared by homogenous mixing of chitosan, HA and nAg followed by freeze drying to obtain a flexible and porous structure. The prepared sponges were characterized using SEM and FT-IR. The porosity, swelling, biodegradation and haemostatic potential of the sponges were also studied. Antibacterial activity of the prepared sponges was analysed using Escherichia coli, Staphylococcus aureus, methicillin-resistant Staphylococcus aureus (MRSA), Pseudomonas aeruginosa and Klebsiella pneumonia. Chitosan-HA/nAg composite sponges showed potent antimicrobial property against the tested organisms. Sponges containing higher nAg (0.005%, 0.01% and 0.02%) concentrations showed antibacterial activity against MRSA. Cytotoxicity and cell attachment studies were done using human dermal fibroblast cells. The nanocomposite sponges showed a nAg concentration dependent toxicity towards fibroblast cells. Our results suggest that this nanocomposite sponges could be used as a potential material for wound dressing for DFU infected with antibiotic resistant bacteria if the optimal concentration of nAg exhibiting antibacterial action with least toxicity towards mammalian cells is identified. (C) 2013 Elsevier B.V. All rights reserved.
引用
收藏
页码:310 / 320
页数:11
相关论文
共 37 条
  • [1] Alexandra C., 2006, INFECT IMMUN, V74, P4950
  • [2] An in vitro assessment of the antibacterial properties and cytotoxicity of nanoparticulate silver bone cement
    Alt, V
    Bechert, T
    Steinrücke, P
    Wagener, M
    Seidel, P
    Dingeldein, E
    Domann, E
    Schnettler, R
    [J]. BIOMATERIALS, 2004, 25 (18) : 4383 - 4391
  • [3] Chitosan-hyaluronan/nano chondroitin sulfate ternary composite sponges for medical use
    Anisha, B. S.
    Sankar, Deepthi
    Mohandas, Annapoorna
    Chennazhi, K. P.
    Nair, Shantikumar V.
    Jayakumar, R.
    [J]. CARBOHYDRATE POLYMERS, 2013, 92 (02) : 1470 - 1476
  • [4] In vivo evaluation of chitosan-PVP-titanium dioxide nanocomposite as wound dressing material
    Archana, D.
    Singh, Brijesh K.
    Dutta, Joydeep
    Dutta, P. K.
    [J]. CARBOHYDRATE POLYMERS, 2013, 95 (01) : 530 - 539
  • [5] Evaluation of chitosan nano dressing for wound healing: Characterization, in vitro and in vivo studies
    Archana, D.
    Dutta, Joydeep
    Dutta, P. K.
    [J]. INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2013, 57 : 193 - 203
  • [6] Toxicity of silver nanoparticles-Nanoparticle or silver ion?
    Beer, Christiane
    Foldbjerg, Rasmus
    Hayashi, Yuya
    Sutherland, Duncan S.
    Autrup, Herman
    [J]. TOXICOLOGY LETTERS, 2012, 208 (03) : 286 - 292
  • [7] Preparation and evaluation of thermo-reversible copolymer hydrogels containing chitosan and hyaluronic acid as injectable cell carriers
    Chen, Jyh-Ping
    Cheng, Tai-Hong
    [J]. POLYMER, 2009, 50 (01) : 107 - 116
  • [8] Chia L.I., 2008, SCIENCE, V319, P1391
  • [9] Methicillin resistant Staphylococcus aureus in patients undergoing major amputation
    Grimble, SAJ
    Magee, TR
    Galland, RB
    [J]. EUROPEAN JOURNAL OF VASCULAR AND ENDOVASCULAR SURGERY, 2001, 22 (03) : 215 - 218
  • [10] Wound dressings in diabetic foot disease
    Hilton, JR
    Williams, DT
    Beuker, B
    Miller, DR
    Harding, KG
    [J]. CLINICAL INFECTIOUS DISEASES, 2004, 39 : S100 - S103